Condition

Pregnancy, High Risk

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 28 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials28

Recruiting11

Common interventions25

Lead sponsors shown15

Clinical trials

28 shown

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal PatientsNCT07540585 · 2026-07-15

NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational DiabetesNCT07560813 · 2026-07-06

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)NCT07293715 · 2026-02-25

Early Detection of Gestational Diabetes Mellitus in PregnancyNCT05388643 · 2025-07-01

Commercial or Open Source Closed Loop Impact on Pregnancy StudyNCT06654713 · 2025-03-13

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesNCT06445946 · 2024-08-01

Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and CoachingNCT05662462 · 2024-07-11

Continuous Glucose Monitor Use in PregnancyNCT05317585 · 2024-05-23

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARENCT05909046 · 2023-07-24

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody SyndromeNCT05786235 · 2022-12-06

Intensive Glycemic Targets in Overweight and Obese Women With Gestational DiabetesNCT05124808 · 2022-03-01

Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCTNCT06490874 · 2025-09-01

Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)NCT05922033 · 2023-10-19

The Effect of Home Midwifery Care Given to Pregnant Women Diagnosed With Gestational Diabetes on Attitudes and Self-CareNCT05670769 · 2023-07-01

mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDMNCT05597943 · 2023-05-01

Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational DiabetesNCT04542148 · 2022-02-10

ACTIVE_NOT_RECRUITING

Gestational Diabetes Monitoring and ManagementNCT06963528 · 2021-12-01

ACTIVE_NOT_RECRUITING

Pregnant Women With Pulmonary Hypertension in ChinaNCT05198206 · 2021-11-01

Mechanisms Behind Severe Insulin Resistance During Pregnancy in Women With Glucose Metabolic Disorders (SIR-MET)NCT04924504 · 2021-05-01

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes MellitusNCT04599075 · 2021-03-15

Hormonal and Inflammatory Changes During Pregnancy in Women With Glucose Metabolic Disorders.NCT04617405 · 2021-01-11

Active Pregnancy Against COVID-19NCT04563065 · 2020-08-01

The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III ObesityNCT03985618 · 2019-09-01

Healthy Diet for Healthy Moms and BabiesNCT03467503 · 2018-05-01

Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of HypertensionNCT03334149 · 2017-11-22

Placental Growth Factor Assessment of Women With Suspected Pre-eclampsiaNCT02881073 · 2017-06-29

Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This SituationNCT03777371 · 2014-01-01

Clinical Benefits of B-Flow UltrasoundNCT02008097 · 2013-10-01

Common interventions

InsulinDRUG3 No interventionsOTHER2 Anti HIV Seropositive Pregnant WomenOTHER1 Blueberry + soluble fiberDIETARY_SUPPLEMENT1 Caesarean sectionPROCEDURE1 Care team coaching for medical and social needs (HUB)BEHAVIORAL1 CGM device - Insulin groupDEVICE1 CGM device - Metformin groupDEVICE1 Collaborative Mental Health Care Program (CMHCP)BEHAVIORAL1 Collection of epidemiological and anamnestic data and collection of biological material (peripheral blood)OTHER1 Commercial AID systemOTHER1 Continuous Glucose MonitorDEVICE1 Continuous Insulin InfusionDRUG1 DEXCOM Continuous Glucose MonitorDEVICE1 Dexcom G6 Professional Continuous Glucose MonitorDEVICE1 DEXCOM G7 PRO Continuous Glucose MonitorDEVICE1 EducationOTHER1 Enhanced First Trimester GDM ScreeningDIAGNOSTIC_TEST1 Exercise programOTHER1 GE LOGIQ E9 Ultrasound SystemDEVICE1 Health Impact Ohio Central Ohio Pathways Hub to address unmet social needsBEHAVIORAL1 Healthy lifestyle adviseOTHER1 Immediate inpatient postpartum OGTTDIAGNOSTIC_TEST1 Induction of LabourPROCEDURE1 Intensive glycemic targetsOTHER1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

insulin, regular, human3 metformin1

Leading sponsors

Ohio State University 7 Indiana University 2 University of Aarhus 2 University of Massachusetts, Worcester 2 University of Oxford 2 Cukurova University 1 First Affiliated Hospital of Chongqing Medical University 1 Gianna Wilkie 1 IRCCS San Raffaele 1 Irish Centre for Fetal and Neonatal Translational Research 1 Kanuni Sultan Suleyman Training and Research Hospital 1 Ottawa Hospital Research Institute 1 Tufts Medical Center 1 Universidad Politecnica de Madrid 1 University of Alabama at Birmingham 1

Trial status mix

RECRUITING11

COMPLETED8

UNKNOWN6

ACTIVE_NOT_RECRUITING2

WITHDRAWN1

Phase mix

NA14

PHASE44

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.